First School of Clinical Medicine of Lanzhou University, Department of Orthopedics, First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Department of Orthopedics, Gansu Provincial Hospital, Lanzhou, Gansu, China.
Mol Cell Biol. 2022 Feb 17;42(2):e0054120. doi: 10.1128/MCB.00541-20. Epub 2021 Dec 13.
Long noncoding RNAs (lncRNAs) have been confirmed as important regulators during osteogenic differentiation. Previous research has disclosed that growth arrest-specific transcript 5 () can promote osteogenic differentiation of human bone marrow mesenchymal stem cells (hBMSCs), but the underlying regulatory mechanism of during the osteogenic differentiation of hBMSCs is unclear. Osteogenic differentiation was induced in hBMSCs by using osteogenic medium (OM). Gene expression was assessed by quantitative real-time PCR (RT-qPCR) or Western blot assays as needed. Alkaline phosphatase (ALP) activity, ALP staining, and alizarin red S (ARS) staining assays were performed to evaluate the impact of , microRNA 382-3p (miR-382-3p), and TATA box binding protein-associated factor 1 () on osteogenic differentiation . The interaction among , miR-382-3p, and was determined by RNA immunoprecipitation (RIP), chromatin immunoprecipitation (ChIP), and luciferase reporter assays. Expression of (transcript variant 2) was downregulated during the osteogenic differentiation of hBMSCs, and its overexpression retarded the osteogenic differentiation of hBMSCs. inhibited miR-382-3p by targeting RNA-directed microRNA degradation (TDMD). miR-382-3p downregulation partially offset the promoted osteogenic differentiation of hBMSCs upon silencing. negatively modulated osteogenic differentiation, and it activated transcription so as to form a positive -miR-382-3p- feedback loop in hBMSCs. This research was the first to reveal that the -miR-382-3p- feedback loop inhibited the osteogenic differentiation of hBMSCs, which provided new clues for exploring the mechanism of osteogenic differentiation and disclosed the potential of as a promising target during osteogenic differentiation.
长链非编码 RNA(lncRNA)已被证实为成骨分化过程中的重要调控因子。先前的研究表明,生长停滞特异性转录物 5()可以促进人骨髓间充质干细胞(hBMSCs)的成骨分化,但在 hBMSCs 的成骨分化过程中,的潜在调控机制尚不清楚。通过使用成骨培养基(OM)诱导 hBMSCs 的成骨分化。根据需要通过定量实时 PCR(RT-qPCR)或 Western blot 分析评估基因表达。通过碱性磷酸酶(ALP)活性、ALP 染色和茜素红 S(ARS)染色分析评估、microRNA 382-3p(miR-382-3p)和 TATA 框结合蛋白相关因子 1()对成骨分化的影响。通过 RNA 免疫沉淀(RIP)、染色质免疫沉淀(ChIP)和荧光素酶报告基因分析确定、miR-382-3p 和之间的相互作用。在 hBMSCs 的成骨分化过程中,的表达下调,其过表达则抑制 hBMSCs 的成骨分化。通过靶向 RNA 指导的 microRNA 降解(TDMD)抑制 miR-382-3p。沉默后,miR-382-3p 的下调部分抵消了 hBMSCs 成骨分化的促进作用。负调控成骨分化,通过形成正向反馈环来激活转录,从而在 hBMSCs 中形成 -miR-382-3p-负反馈环。这项研究首次揭示了 -miR-382-3p-负反馈环抑制 hBMSCs 的成骨分化,为探索成骨分化机制提供了新线索,并揭示了在成骨分化过程中作为有前途的靶标的潜力。